Researchers sought to determine whether inhibitor incidence with N8-GP prophylaxis would be within range for patients with previously untreated hemophilia A.
Researchers sought to determine whether there were any changes in prophylactic treatment practices among previously untreated patients with hemophilia.
Researchers sought to compare exercise with intranasal desmopressin to examine changes in factor VIII activity in adolescent male patients with mild hemophilia A.
Researchers sought to determine whether prophylactic tranexamic acid would improve bleeding outcomes in patients treated for hematologic malignancy at risk of thrombocytopenia.
Researchers sought to determine whether incorporating a clinical pharmacist into the comprehensive care model for patients with hemophilia would improve outcomes.
Researchers sought to determine whether an assay using flow cytometry may help to diagnose patients who have vaccine-induced immune thrombotic thrombocytopenia.
Researchers sought to determine whether extended half-life recombinant factor VIII would lead to a lower ABR in pediatric patients with severe hemophilia A.
In a randomized clinical trial, researchers evaluated clinical outcomes following fibrinogen administration in patients with severe TBI and concurrent hypofibrinogenemia.
Researchers sought to determine whether older patients with hemophilia would have similar quality of life scores and comorbidities compared with younger patients.
Researchers characterized the abundance and impacts of extracellular vesicles associated with recombinant factor VIIa treatment in patients with hemophilia.
Researchers sought to determine whether home nursing based on smart medical Internet of Things systems could improve the quality of life of patients with hemophilia.